Clinical Trials Logo

Clinical Trial Summary

Clinical and analytical tests will be performed based on risk assessment and system specifications to verify that the performance of the investigational device is in accordance with its specifications.


Clinical Trial Description

Comparison and precision studies will be conducted in up to 5 clinical sites in Israel and the US, and include: - Precision - Sample Matrix Comparison - Method comparison study and flagging analysis - Reference interval range ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03595501
Study type Observational
Source Sight Diagnostics
Contact
Status Completed
Phase
Start date June 20, 2018
Completion date August 25, 2019

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05763186 - The Right Amount of Purge Useful for Blood Sampling on PiccLine (PiccLine) N/A
Completed NCT02835937 - Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status N/A
Completed NCT01418846 - Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients N/A
Not yet recruiting NCT04618848 - Performance Evaluation Study
Recruiting NCT04931329 - Onco-haematology Vigilance Card
Not yet recruiting NCT06007794 - Correlation Between Ultrasound-assessed Quadriceps Muscle Mass and Baseline Whole-body Densitometry Muscle Index in the Post-cancer Population (JUMP Research II) N/A
Recruiting NCT05242341 - Increase Understanding and Safety of Treatment N/A
Completed NCT01300026 - AMG 319 Lymphoid Malignancy FIH Phase 1
Completed NCT00066092 - Pegfilgrastim PBPC Mobilization Study Phase 2
Completed NCT00472290 - Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) N/A